Xeloda (capecitabine) for breast cancer. Adjuvant settings possible?

From: Christian Bergmann (christian.bergmann_02-06_at_mail-4-you.de)
Date: 07/11/04 

Date: Sun, 11 Jul 2004 23:29:58 +0200

Xeloda (capecitabine) is commonly used as treatment for metastatic breast
cancer. As agents of choice in the adjuvant settings usually anthracyclines
and taxanes are used. I have heard that there are any studies planed to
compare the effect of oral single-agent capecitamine vs. established
anthracyclines as adjuvant therapy in postmenopausal women with breast
cancer. Do you know where this is done or do you even know any results of
this studies?